Cargando…
Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.
Ovarian cancer (OC) is one of the most lethal type of cancer in women due to a lack of effective targeted therapies and high rates of treatment resistance and disease recurrence. Recently Poly (ADP-ribose) polymerase inhibitors (PARPi) have shown promise as chemotherapeutic agents; however, their ef...
Autores principales: | Mani, Chinnadurai, Tripathi, Kaushlendra, Chaudhary, Sandeep, Somasagara, Ranganatha R., Rocconi, Rodney P., Crasto, Chiquito, Reedy, Mark, Athar, Mohammad, Palle, Komaraiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361230/ https://www.ncbi.nlm.nih.gov/pubmed/34380074 http://dx.doi.org/10.1016/j.neo.2021.06.010 |
Ejemplares similares
-
Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance
por: Palle, Komaraiah, et al.
Publicado: (2015) -
Rad18 is required for functional interactions between FANCD2, BRCA2, and Rad51 to repair DNA topoisomerase 1-poisons induced lesions and promote fork recovery
por: Tripathi, Kaushlendra, et al.
Publicado: (2016) -
RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance
por: Somasagara, Ranganatha R., et al.
Publicado: (2017) -
FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase-3 dependent degradation
por: Clark, David W., et al.
Publicado: (2015) -
Case Report: Intra-Tumoral Vaccinations of Quadrivalent HPV-L1 Peptide Vaccine With Topical TLR-7 Agonist Following Recurrence: Complete Resolution of HPV-HR-Associated Gynecologic Squamous Cell Carcinomas in Two Patients
por: Reedy, Mark, et al.
Publicado: (2021)